前收市價 | 1.2300 |
開市 | 1.2200 |
買盤 | 1.2300 x 200 |
賣出價 | 1.2700 x 100 |
今日波幅 | 1.2100 - 1.2600 |
52 週波幅 | 0.5900 - 11.1200 |
成交量 | |
平均成交量 | 1,175,430 |
市值 | 87.238M |
Beta 值 (5 年,每月) | 0.23 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.2700 |
業績公佈日 | 2024年5月06日 - 2024年5月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 1.80 |
Here is how Aclaris Therapeutics (ACRS) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
Here is how Aclaris Therapeutics (ACRS) and ASLAN Pharmaceuticals Ltd. (ASLN) have performed compared to their sector so far this year.
Aclaris (ACRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).